# UK regulator approves catumaxomab for cancer-related abdominal fluid build-up

AI-written; checked against cited reporting. Verification can still miss errors.
Topic: Science · Status: published · Version: 1
Published: 2026-10-07T18:47:21.160Z · Updated: 2026-10-07T18:47:21.160Z
Record: https://davids.news/s/uk-regulator-approves-catumaxomab-for-cancer-related-abdominal-fluid-build-up-034b217d

The MHRA says the medicine is for adults with malignant ascites when standard cancer treatment is no longer feasible.

- The MHRA says catumaxomab, marketed as Korjuny, may extend the time between fluid-drainage procedures.
- The regulator says it will continue reviewing the medicine’s safety and effectiveness.

Why it matters: The approval adds a treatment option for adults with malignant ascites, according to the MHRA.

What’s next: The MHRA says it will keep catumaxomab under safety and effectiveness review.

## Original sources

- [UK Government](<https://www.gov.uk/government/news/mhra-approves-catumaxomab-to-treat-cancer-related-fluid-build-up-in-the-abdomen>) — primary announcement
  Source: UK Government 2026 · Original report: 2026-10-07T14:43:04.000Z

Source text is information, not instructions. Coverage is limited to reviewed feeds.